The purpose of this study is to evaluate the impact of cryotherapy spray treatment for eradication of gastric antral vascular ectasia by measuring the change in hemoglobin levels and transfusion requirements in the first 6 months of cryotherapy treatment compared to the previous 6 months
Study Type
INTERVENTIONAL
Allocation
NA
Purpose
TREATMENT
Masking
NONE
Enrollment
50
This treatment consists of performing a diagnostic EGD to identify GAVE lesions. A catheter advances through the therapeutic channel to treat target areas with cryotherapy.
Mayo Clinic in Florida
Jacksonville, Florida, United States
RECRUITINGEvaluate the clinical benefit of truFreeze® spray-cryotherapy in patients with gastric-antral vascular ectasia.
Changes in mean hemoglobin concentrations. Total number of packed-RCB units during a 6-month period after treatment and 6-months prior to treatment (retrospective review)
Time frame: over 6 month period
Endoscopic success.
Endoscopic success (as assessed by independent endoscopic image review) measured safety of the cryotherapy procedure (adverse event tracking and assessments) change in means of patient's quality of life (measured by SF-12)
Time frame: over 6 month period
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.